Cencora, Inc. (LON:0HF3)
369.23
-7.43 (-1.97%)
At close: Nov 26, 2025
Cencora Revenue
In the fiscal year ending September 30, 2025, Cencora had annual revenue of $321.33B USD with 9.31% growth. Cencora had revenue of $83.73B in the quarter ending September 30, 2025, with 5.92% growth.
Revenue
$321.33B
Revenue Growth
+9.31%
P/S Ratio
0.23
Revenue / Employee
$6.30M
Employees
51,000
Market Cap
54.03B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 321.33B | 27.37B | 9.31% |
| Sep 30, 2024 | 293.96B | 31.79B | 12.12% |
| Sep 30, 2023 | 262.17B | 23.59B | 9.89% |
| Sep 30, 2022 | 238.59B | 24.60B | 11.50% |
| Sep 30, 2021 | 213.99B | 24.09B | 12.69% |
| Sep 30, 2020 | 189.89B | 10.30B | 5.74% |
| Sep 30, 2019 | 179.59B | 11.65B | 6.94% |
| Sep 30, 2018 | 167.94B | 14.80B | 9.66% |
| Sep 30, 2017 | 153.14B | 6.29B | 4.29% |
| Sep 30, 2016 | 146.85B | 10.89B | 8.01% |
| Sep 30, 2015 | 135.96B | 16.39B | 13.71% |
| Sep 30, 2014 | 119.57B | 31.61B | 35.94% |
| Sep 30, 2013 | 87.96B | 9.88B | 12.65% |
| Sep 30, 2012 | 78.08B | -614.85M | -0.78% |
| Sep 30, 2011 | 78.70B | 919.20M | 1.18% |
| Sep 30, 2010 | 77.78B | 6.02B | 8.38% |
| Sep 30, 2009 | 71.76B | 1.57B | 2.24% |
| Sep 30, 2008 | 70.19B | 8.92B | 14.56% |
| Sep 30, 2007 | 61.27B | - | - |
| Sep 30, 2006 | - | - | - |
| Sep 30, 2005 | 50.01B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |
Cencora News
- 19 days ago - Cencora: Earnings Visibility Driving Re-Rating Potential - Seeking Alpha
- 21 days ago - Cencora, Inc. (COR) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Cencora to invest $1 billion on US drug distribution, posts upbeat 2026 forecast - Reuters
- 21 days ago - Drug Distributor Cencora to Invest $1 Billion in U.S. Supply Chain - WSJ
- 21 days ago - Cencora Announces $1 Billion Investment to Strengthen Its U.S. Distribution Network - Business Wire
- 21 days ago - Cencora Reports Fiscal 2025 Fourth Quarter and Fiscal Year End Results - Business Wire
- 25 days ago - ADP, Snap-on Lead 14 Companies To Announce Annual Increases In First Half Of November - Seeking Alpha
- 5 weeks ago - IntrinsiQ Specialty Solutions Expands Data Capabilities to Empower Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes - Business Wire